Who, What & Why?
 Search OA Now

Who, What & Why

What is Current Controlled Trials?
Current Controlled Trials (CCT) is an online publisher dedicated to providing services in the area of randomized controlled trials. These include trial registration and trial hosting. CCT has two main Open Access projects: the International Standard Randomised Controlled Trial Number (ISRCTN) scheme and the metaRegister of Controlled Trials.

The ISRCTN scheme assigns a unique randomized 8-digit number to each trial against a one-off administrative charge. This ensures that a trial can be tracked unambiguously throughout its life cycle. The metaRegister is an international compilation of registers of completed and ongoing trials. The metaRegister includes randomized controlled trials sponsored by the UK Medical Research Council (MRC), four National Health Service (NHS) registers, the National Library of Medicine's ClinicalTrials.gov register and the US Department of Veterans Affairs Co-operative Studies Program. Access to the ISRCTN Register and metaRegister is free online. CCT provides access to over 15,000 trial records in all areas of health care.

Who is behind Current Controlled Trials?
Current Controlled Trials Ltd is part of the Current Science Group of biomedical publishing companies, which includes BioMed Central (publisher of Open Access Now). The Managing Director of Current Controlled Trials Ltd is Anne Greenwood who has over twenty years of experience in academic publishing. The company benefits from guidance by an international Advisory Group, including academics, doctors and healthcare specialists. The Advisory Group is chaired by Gerd Antes of the German Cochrane Centre.

Why does Current Controlled Trials exist?
Current Controlled Trials Ltd launched the CCT website in late 1998 with the aim of increasing the availability and exchange of information about ongoing randomized controlled trials worldwide. CCT provides detailed and accurate information to researchers and clinicians about trials being conducted in all areas of healthcare; helps research funding agencies (public, commercial or charitable) to avoid duplicating research and to promote collaborations; and provides information that helps patients and clinicians to decide whether to actively participate in, and contribute to, ongoing clinical trials studies.

www.controlled-trials.com

 

 
 

Open Access Now is published by BioMed Central.
Editor: Jonathan B Weitzman.